ZuriENRA 80
Enramycin 8%
Polypeptide antibiotic that prevents necrotic enteritis through selective, localised intestinal activity.
About ZuriENRA 80
ZuriENRA 80 delivers enramycin at 80 g per kg, a polypeptide antibiotic produced by Streptomyces fungicidicus with potent and selective activity against Gram-positive intestinal pathogens.
Why choose ZuriENRA 80
Potent Anti-Clostridial Activity
Exceptional in vitro and in vivo activity against Clostridium perfringens types A and C.
No Systemic Absorption
Polypeptide structure prevents gut absorption, eliminating residue and withdrawal period concerns.
Unique Mechanism
Cell wall synthesis inhibition through a distinct polypeptide mechanism unrelated to bacitracin.
NE Prevention at Low Dose
Effective at very low in-feed concentrations (70–125 ppm active).
Gut Integrity Maintenance
Protects gut mucosal integrity and maintains the absorptive capacity of the intestine.
Compatible with Coccidiostats
Can be combined with all major coccidiostats in the feed program.
How ZuriENRA 80 works
Cell Wall Synthesis Inhibition
Enramycin inhibits transglycosylation in bacterial peptidoglycan synthesis.
Gram-Positive Selectivity
The polypeptide structure confers selectivity for Gram-positive pathogens.
Luminal Localisation
The non-absorbed polypeptide remains active in the intestinal lumen.
Toxin Prevention
By preventing C. perfringens growth, enramycin eliminates the source of alpha and NetB toxins.
Recommended dosage & use
Always follow veterinary guidance. The dosages below are standard recommendations; higher doses may be advised during disease challenges or deficiency conditions.
Ready to try ZuriENRA 80?
Submit an enquiry and our technical team will come back with pricing, availability, and programme support within 24 hours.